Mebanazine
A monoamine oxidase inhibitor used as an antidepressant
Mebanazine is a monoamine oxidase inhibitor (MAOI) that was used as an antidepressant in the treatment of depression. It belongs to the class of hydrazine derivatives and functions by inhibiting the activity of the enzyme monoamine oxidase, which leads to an increase in the levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain.
Pharmacology[edit | edit source]
Mebanazine works by irreversibly binding to the monoamine oxidase enzyme, thereby preventing the breakdown of monoamine neurotransmitters. This results in increased concentrations of these neurotransmitters in the synaptic cleft, which is thought to contribute to its antidepressant effects. The inhibition of monoamine oxidase can lead to increased levels of tyramine, a naturally occurring monoamine compound, which can cause hypertensive crises if dietary restrictions are not followed.
Clinical Use[edit | edit source]
Mebanazine was primarily used in the treatment of major depressive disorder, particularly in patients who did not respond to other types of antidepressants. Due to its potential for serious side effects and interactions with certain foods and medications, its use has declined with the development of newer antidepressants that have more favorable safety profiles.
Side Effects[edit | edit source]
Common side effects of Mebanazine include dizziness, dry mouth, insomnia, and weight gain. More serious side effects can include hypertensive crisis, especially when taken with foods high in tyramine, such as aged cheeses and cured meats. Patients taking Mebanazine were advised to adhere to a strict diet to avoid these interactions.
Discontinuation[edit | edit source]
The use of Mebanazine has largely been discontinued in favor of newer antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which have fewer dietary restrictions and a more favorable side effect profile.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD